文献速递心外重症与机械循环支持

左心室辅助装置支持下二尖瓣反流的缓解

Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
PubMed 文献 · Ann Thorac Surg · 2017-05-17

该研究回顾了2006年3月至2015年5月238例连续接受左心室辅助装置(LVAD)植入的终末期心衰患者,按术前二尖瓣反流(MR)程度分为<中重度(n=195)与≥中重度(n=43)两组。结果显示两组术后血流动力学均显著改善,MR显著缓解,180天时≥中重度MR组仅4/168(2.4%)存在MR,且并发症与生存无差异。结论认为LVAD植入可纠正功能性MR,同期行二尖瓣修复或置换不必要。

要点

  • LVAD植入后各组MR均显著缓解,180天时≥中重度MR仅剩2.4%。
  • 术前MR程度不影响LVAD术后并发症与生存。
  • 同期二尖瓣修复或置换在LVAD植入时可能不必要。

核心结论

  • LVAD植入通过左室卸载促进逆重构,可纠正各严重程度的功能性MR,且180天时缓解持续。
  • 未纠正的MR在<中重度与≥中重度组间无生存差异,同期二尖瓣修复或置换不必要。

研究设计与样本

  • 回顾性队列研究,纳入2006年3月至2015年5月238例连续接受LVAD植入的患者。
  • 按术前MR程度分组:<中重度MR组n=195,≥中重度MR组n=43。

主要发现

  • 两组术后中心静脉压、肺动脉压、肺毛细血管楔压、肺血管阻力、心脏指数、左室射血分数及左室舒张末内径均显著改善。
  • 两组MR均显著缓解,180天时≥中重度MR组仅4/168(2.4%)患者存在MR。
  • 两组术后并发症与生存无差异。

关键数值与推荐

  • MR分组阈值:<中重度 vs ≥中重度。
  • 180天时≥中重度MR组MR缓解情况:4/168(2.4%)存在MR。

临床怎么用

  • LVAD植入时对功能性MR可不同期行二尖瓣修复或置换,依赖LVAD卸载使MR缓解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac valve disease is common in patients with end-stage heart failure undergoing left ventricular assist device implantation (LVAD). The aim of this study was to determine if preoperative mitral regurgitation (MR) affects outcomes and hemodynamics in patients after LVAD implantation. METHODS: From March 2006 through May 2015, 238 consecutive patients underwent LVAD implantation. Patient cohorts included less than moderate to severe MR (< moderate-severe, n = 195) and greater than or equal to moderate to severe MR (≥ moderate-severe, n = 43). Demographics, operative characteristics, postoperative outcomes, hemodynamic and echocardiographic data, and resolution of MR were compared at 30 and 180 days post-LVAD. RESULTS: Significant hemodynamic improvements were seen in central venous pressure, pulmonary arterial pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance, cardiac index, left ventricular ejection fraction, and left ventricular end-diastolic diameter, irrespective of preoperative MR severity. Significant resolution of MR occurred across both cohorts, with only 4 of 168 (2.4%) patients with ≥ moderate-severe MR at 180 days post-LVAD. There were no differences in complications or survival between MR severity cohorts postoperatively. CONCLUSIONS: LVAD implantation unloads the left ventricle to promote left ventricle reverse remodeling and correct functional MR across all severity levels. The resolution of MR is sustained at 180 days post-LVAD. These results coupled with no survival difference with uncorrected MR between < moderate-severe MR and ≥ moderate-severe MR makes concomitant mitral valve repair or replacement at the time of LVAD implantation unnecessary.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Goodwin M, Nemeh HW, Borgi J, et al. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support. Ann Thorac Surg. 2017. PMID: 28527962. doi:10.1016/j.athoracsur.2017.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。